1 unknown. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
Follow Hypopigmentation: new trials by email Literature Review of Hypopigmentation trials Research Report on Hypopigmentation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of Tofacitinib in Vitiligo Patients JAK-2 inhibitor, Topical corticosteroid - Vitiligo, Effect of Drug | Early Phase 1 | Unknown | Pi Research Consultancy Center, Bangladesh | 80 | 2022-05-30 | 2022-03-24 |
Vitiligo (1)
Pigmentation Disorders (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Adrenal Cortex Hormones (1) · tofacitinib (1)
Pi Research Consultancy Center, Bangladesh (1)